Vx Pharma offers a full range of routine diagnostic and screening tests, including infectious diseases and quantitative molecular testing.

Our close relationship with Motion Pathology Services—a wholly owned subsidiary of Medrock Group, a holding company focused on chronic care health offerings to oncology, diabetes and HIV-infected patients—enables us to offer all screening and routine monitoring blood-work as part of our clinical trials offering. This enables significant cost and logistics advantages over our competitors. Our laboratory is located at our primary trial site within The Innovation Hub, Africa’s first internationally accredited Science and Technology Park, a leading knowledge-intensive business cluster in Gauteng, South Africa.

Motion Pathology Services is fully committed, through accreditation, to international service competence regulations that instil industry confidence and give peace of mind to companies and individuals. To secure economic and social well-being for all, the South African National Accreditation System (SANAS) sets standards for, and gives formal recognition of, test facilities to carry out their tasks in a competent manner. Vx Pharma is in the process of obtaining accreditation by SANAS for ISO 15189.